2019
DOI: 10.1016/j.avsg.2018.11.026
|View full text |Cite|
|
Sign up to set email alerts
|

Neutrophil-to-Lymphocyte Ratio: A Comparative Study of Rupture to Nonruptured Infrarenal Abdominal Aortic Aneurysm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 27 publications
0
19
0
Order By: Relevance
“…1. After reviewing the full-text articles, the remaining 14 observational studies were included in current meta-analysis [13][14][15][16][17][18][19][20][21][22][23][24][25][26].…”
Section: General Characteristic Of Studies Included In the Metaanalysismentioning
confidence: 99%
See 2 more Smart Citations
“…1. After reviewing the full-text articles, the remaining 14 observational studies were included in current meta-analysis [13][14][15][16][17][18][19][20][21][22][23][24][25][26].…”
Section: General Characteristic Of Studies Included In the Metaanalysismentioning
confidence: 99%
“…Seven studies also investigated the prognostic value of high NLR for mortality in aortic disease, the outcome was mortality [14,[21][22][23][24][25][26]. One thousand one hundred thirty-nine aortic disease patients in the high NLR group, and 1824 aortic disease patients in the low NLR group were included in meta-analysis (Fig.…”
Section: Prognostic Value Of High Nlr For Mortality In Aortic Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…Particularly, NLR is unlikely to be affected by various physiological conditions such as dehydration and exercise, despite these conditions may affect the absolute number of the individual cell type [15]. Second, and most prominently, NLR is the ratio of two different types of immune cells which serve in complementary immune pathways [16]. The neutrophil count reflects ongoing inflammation, whereas the lymphocyte count reflects the regulatory immune pathway [17].…”
Section: Introductionmentioning
confidence: 99%
“…Besides, these studies, as mentioned earlier, mainly investigated the relationship between NLR and the occurrence of HT in patients receiving thrombolytic therapy [16]. Although thrombolytic therapy such as recombinant tissue plasminogen activator rtPA is considered the first-line approach for the management of AIS, it is undoubtedly a risk factor for HT.…”
Section: Introductionmentioning
confidence: 99%